Payment overview · 2025
General Payments
$74.52
4 reported records · 2 companies
Healthcare provider profile · identity verified
Asad Moiz Ali, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BRADENTON, FL · NPI 1790715233
Verified facts
What the public records show
CMS Open Payments records show Asad Moiz Ali, MD received $74.52 in general payments during 2025 across 4 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 64.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $47.90 | 64.3% | 3 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $26.62 | 35.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $74.52 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $47.90 | 3 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $26.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 466 | 79 |
| Furosemide | Furosemide | 368 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 347 | 60 |
| Amlodipine Besylate | Amlodipine Besylate | 321 | 61 |
| Potassium Chloride | Potassium Chloride | 320 | 53 |
| Levothyroxine Sodium | Levothyroxine Sodium | 318 | 45 |
| Gabapentin | Gabapentin | 305 | 54 |
| Eliquis | Apixaban | 292 | 33 |
| Lisinopril | Lisinopril | 241 | 50 |
| Trazodone Hcl | Trazodone Hcl | 226 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 210 | 39 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 174 | 41 |
| Sertraline Hcl | Sertraline Hcl | 174 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 151 | 23 |
| Metformin Hcl | Metformin Hcl | 148 | 26 |
| Carvedilol | Carvedilol | 138 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 134 | 33 |
| Alprazolam | Alprazolam | 125 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 123 | 15 |
| Lactulose | Lactulose | 120 | 21 |
| Levetiracetam | Levetiracetam | 117 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 115 | 21 |
| Xarelto | Rivaroxaban | 114 | suppressed |
| Losartan Potassium | Losartan Potassium | 113 | 26 |
| Divalproex Sodium | Divalproex Sodium | 107 | 14 |
| Tramadol Hcl | Tramadol Hcl | 104 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 97 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 95 | 21 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 90 | 58 |
| Clonazepam | Clonazepam | 88 | 13 |
| Pantoprazole Sodium | Pantoprazole Sodium | 87 | 24 |
| Simvastatin | Simvastatin | 87 | 17 |
| Nifedipine Er | Nifedipine | 81 | 15 |
| Buspirone Hcl | Buspirone Hcl | 79 | 16 |
| Mirtazapine | Mirtazapine | 79 | 18 |
| Benztropine Mesylate | Benztropine Mesylate | 77 | 11 |
| Oxcarbazepine | Oxcarbazepine | 75 | 11 |
| Ozempic | Semaglutide | 74 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 14 |
| Allopurinol | Allopurinol | 73 | 13 |
| Omeprazole | Omeprazole | 73 | 22 |
| Jardiance | Empagliflozin | 70 | suppressed |
| Glipizide | Glipizide | 66 | 17 |
| Baclofen | Baclofen | 65 | 11 |
| Spironolactone | Spironolactone | 65 | 11 |
| Ibuprofen | Ibuprofen | 60 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 60 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 60 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 59 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 57 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 57 | 12 |
| Metoprolol Succinate | Metoprolol Succinate | 57 | 14 |
| Meloxicam | Meloxicam | 54 | 12 |
| Risperidone | Risperidone | 47 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 45 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 45 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Nystatin | Nystatin | 45 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | suppressed |
| Entresto | Sacubitril/Valsartan | 44 | suppressed |
| Memantine Hcl | Memantine Hcl | 43 | 11 |
| Mounjaro | Tirzepatide | 42 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 42 | 11 |
| Methylprednisolone | Methylprednisolone | 41 | 22 |
| Diltiazem Hcl | Diltiazem Hcl | 40 | suppressed |
| Lorazepam | Lorazepam | 40 | suppressed |
| Zonisamide | Zonisamide | 39 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | suppressed |
| Olanzapine | Olanzapine | 37 | suppressed |
| Sucralfate | Sucralfate | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 36 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Latanoprost | Latanoprost | 35 | suppressed |
| Temazepam | Temazepam | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 20 |
| Glimepiride | Glimepiride | 34 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Clonidine | Clonidine | 31 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 31 | suppressed |
| Glipizide Er | Glipizide | 30 | suppressed |
| Levemir | Insulin Detemir | 30 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Glatiramer Acetate | Glatiramer Acetate | 29 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Novolin R | Insulin Regular, Human | 28 | suppressed |
| Prednisone | Prednisone | 28 | 11 |
| Novolog | Insulin Aspart | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 19 |
| Sulfasalazine | Sulfasalazine | 27 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 26 | suppressed |
| Ertapenem | Ertapenem Sodium | 26 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 25 | suppressed |
| Metolazone | Metolazone | 25 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Pregabalin | Pregabalin | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 23 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 23 | suppressed |
| Azithromycin | Azithromycin | 22 | 20 |
| Creon | Lipase/Protease/Amylase | 22 | suppressed |
| Humulin R | Insulin Regular, Human | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | 11 |
| Briviact | Brivaracetam | 20 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 20 | 13 |
| Digoxin | Digoxin | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 20 | 13 |
| Telmisartan | Telmisartan | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Valproic Acid | Valproic Acid | 19 | suppressed |
| Nystop | Nystatin | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 16 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 16 | suppressed |
| Famotidine | Famotidine | 16 | suppressed |
| Ingrezza | Valbenazine Tosylate | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Atenolol | Atenolol | 15 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Ezetimibe | Ezetimibe | 15 | suppressed |
| Haloperidol | Haloperidol | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Restasis | Cyclosporine | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Dalfampridine Er | Dalfampridine | 12 | suppressed |
| Dexamethasone | Dexamethasone | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Vimpat | Lacosamide | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $74.52 · 4 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error